サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1455738

牛初乳（コロストラム）の世界市場-2023年～2030年

Global Bovine Colostrum Market - 2023-2030

出版日
ページ情報
英文 210 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.28円
牛初乳（コロストラム）の世界市場-2023年～2030年
出版日: 2024年03月26日
発行: DataM Intelligence
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

牛初乳（コロストラム）の世界市場は、2022年に32億1,000万米ドルに達し、2023年から2030年の予測期間中にCAGR 6.21％で成長し、2030年には51億9,000万米ドルに達すると予測されています。

牛初乳は、マクロおよびミクロ栄養素、免疫グロブリン、抗微生物活性を持つペプチドの豊富な天然供給源であり、一般的な健康増進と免疫サポートに役立つことから、消費者が栄養補助食品としてこの牛初乳を大いに採用しているためです。

また、特殊な栄養価の高い製品に対する需要が消費者の間で高まっているため、製造企業は革新的な製品を開発しています。例えば、2022年11月、PanTheryx社は、医療従事者チャネル向けに処方された超強力免疫サポートおよび消化器健康サプリメントであるLife's First Naturals PROウシサプリメントを発売しました。

初乳の栄養補助食品とアジア太平洋地域は、世界の牛初乳市場で優位性を示しています。この地域は、生乳生産率と需要が高く、牛初乳製品の生産に適しているため、世界の牛初乳市場を牽引することができます。

ダイナミクス

健康とウェルネスの動向の増加

消費者は、健康全般をサポートするために自然で栄養価の高いサプリメントを求めるようになってきています。牛初乳は、様々な栄養素と生物活性化合物の豊富な供給源であるため、この需要に合致しており、免疫システムと腸の健康増進にも役立ちます。したがって、健康とウェルネスの動向の高まりは、世界の牛初乳市場の牽引役となる可能性があります。

がんの増加

プロバイオティクスの異常は、がんを引き起こす可能性があり、がんの有病率は消費者の間で上昇しています。例えば、世界保健機関（WHO）の報告によると、大腸がんは世界で3番目に多いがんで、全がん患者の約10％を占め、がん関連死亡の世界第2位の原因となっています。大腸がんは高齢者に多く、50歳以上に多く発症します。

加えて、製造企業はより多くの消費者層を惹きつけるため、幅広い製品の開発に注力しています。例えば、2022年11月、APSとSunplusは、新しい牛初乳製品を開発するための複数年にわたる戦略的パートナーシップを発表しました。この戦略的提携により、APSはSunplusのnatrapure cbps粉ミルクに初乳の基礎蛋白質と免疫グロブリンgを配合した新製品をデビューさせる予定です。

乳糖不耐症の増加

乳糖不耐症は、牛乳や乳製品に含まれる糖の一種である乳糖を消化できない消化器疾患です。2023年のMedline Plusの報告によると、乳糖不耐症の患者数は増加傾向にあります。乳幼児期以降に乳糖を消化する能力が低下する人は、全人口の約65％に上ると推定されています。この症状は特に東アジア地域に多いです。その結果、この高い有病率は、小規模な消費者ベースの市場を制限する可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 健康とウェルネスの動向の増加
      • がんの増加
    • 抑制要因
      • 乳糖不耐症の増加
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • DMIの見解

第6章 COVID-19分析

第7章 性質別

  • 有機
  • 従来型

第8章 形態別

  • 液体
  • 粉末
  • カプセル
  • 錠剤

第9章 流通チャネル別

  • ハイパーマーケット/スーパーマーケット
  • 専門店
  • コンビニエンスストア
  • その他

第10章 用途別

  • 栄養補助食品
  • 機能性食品
  • 動物栄養
  • 化粧品
  • 乳児用調製粉乳
  • 医薬品
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Colostrum BioTec GmbH
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Zuche Pharmaceuticals.
  • Biodane Pharma A/S
  • Agati Healthcare
  • Vivesa holding s.r.o.
  • Cure Nutraceutical PVT. LTD
  • PanTheryx, Inc.
  • NOW Health Group, Inc.
  • Sterling Technology
  • Farbest Brands

第14章 付録

目次
Product Code: FB8180

Overview

Global Bovine Colostrum Market reached US$ 3.21 billion in 2022 and is expected to reach US$ 5.19 billion by 2030, growing with a CAGR of 6.21% during the forecast period 2023-2030.

The global bovine colostrum market has witnessed significant growth and transformations over the years, as consumers are highly adopting this bovine colostrum as a dietary supplement as it is a rich natural source of macro- and micro-nutrients, immunoglobulins, and peptides with anti-microbial activity, and it helps to promote general health and immune support.

In addition, as the demand for specialty nutritious products is rising among consumers, manufacturing companies are developing innovative products. For instance, in November 2022, PanTheryx launched Life's First Naturals PRO bovine supplement, an extra-strength immune support and digestive health supplement formulated for the health care practitioner channel.

The dietary supplements of colostrum and Asia-Pacific region show the dominance in global bovine colostrum market, as the milk production rate and demand are high in this region, which aligns the production of bovine colostrum products, hence, it can help in driving the global bovine colostrum market.

Dynamics

Increase in Health and Wellness Trends

Consumers are increasingly seeking natural and nutritional supplements to support their overall well-being. Bovine colostrum, being a rich source of various nutrients and bioactive compounds, aligns with this demand, and also, helps in enhancing the immune system, and gut health. Hence, the rising health and wellness trends can contribute to driving the global bovine colostrum market.

Furthermore, manufacturing companies are launching novel colostrum products in their portfolios. For instance, in May 2022, Pantheryx, a digestive and immune support ingredients company specializing in colostrum, launched a colostrum with probiotic strains for children's and adults' dietary supplements. The new formulation capability creates combination products with colostrum and strains such as Bifidobacterium animalis BB-12, Lactobacillus rhamnosus LGG+, Lactobacillus plantarum HEAL9, Lactobacillus paracasei 8700:2, and B. subtilis DE111.

Increasing Prevalences Of Colostrum Cancers

The probiotic disorder can cause colostrum cancer, and the prevalence of colostrum cancer is rising among consumers. For instance, according to a World Health Organization (WHO) report, colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases, and is the second leading cause of cancer-related deaths worldwide. It predominantly affects older individuals, with most cases occurring in people aged 50 and above.

In addition, manufacturing companies focus on developing a wide range of products to attract larger consumer bases. For instance, in November 2022, APS and Sunplus, announced a multi-year strategic partnership to develop new bovine colostrum products. Through the strategic partnership, APS will debut its new colostrum basic protein and immunoglobulin g formula in sunplus's natrapure cbps milk powder.

Rising Prevalence of Lactose Intolerance

Lactose intolerance is a digestive disorder where the body is unable to digest lactose, a type of sugar found in milk and dairy products. According to a report by Medline Plus in 2023, the number of people with lactose intolerance has been increasing. It is estimated that around 65% of the human population has a reduced ability to digest lactose after infancy. This condition is particularly prevalent in the East Asian region. As a result, this high prevalence rate can limit the market for smaller consumer bases.

Segment Analysis

The global bovine colostrum market is segmented based on nature, form, distribution channel, application, and region.

Increase in Adoption of Colostrum as a Dietary Supplement

The dietary supplements of colostrum have the maximum share in the global bovine colostrum market, as colostrum has high nutritional value, natural macro- and micro-nutrients, immunoglobulins, and others, the consumption of colostrum helps in improving the immune system to fight against diseases.

Furthermore, supplement-producing companies are launching innovative products. For instance, in August 2022, The Roots Brands is unveiling a one-of-a-kind blend of hydrolyzed bovine collagen and whole colostrum powder as a youth-enhancing supplement, which is Dubbed Give Me Back My Youth (GMBMY), is sourced from cows. it helps to promote type types I and Ill collagen in humans, and also boosts skin hydration, enhancing suppleness and minimizing wrinkles.

Geographical Penetration

High Milk Production

Asia-Pacific has been a dominant force in the global cow colostrum market and its significant growth. From ancient times milk and milk products have been part of the consumer's diet in this region, also the demand for cow colostrum products is rising especially in infant foods as they provide antibodies and enhance the immune health.

Furthermore, the production rate for milk is high in this region, for instance, according to the Ministry of Fisheries, Animal Husbandry & Dairying reports the milk industry has raised, since the launch of Operation Flood program. India is the largest producer of milk in the world, contributing 23% of global milk production.

Competitive Landscape

The major global players in the market include Colostrum BioTec GmbH, Zuche Pharmaceuticals., Biodane Pharma A/S, Agati Healthcare, Vivesa holding s.r.o., Cure Nutraceutical PVT. LTD, PanTheryx, Inc., NOW Health Group, Inc., Sterling Technology, and Farbest Brands

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global bovine colostrum market. Many countries have imposed lockdown restrictions which have impacted the distribution channel, exports, and imports of the products.

Additionally, COVID-19 has created opportunities for manufacturers to develop innovative products with beneficial effects and to support the market, for instance, in May 2020, The Surat District Cooperative Milk Producers Union Limited developed cow colostrum powder' Sumul Immune powder, an immunity booster to protect COVID-19-positive patients, it has albumin, globulin, and Gama globulin. It is rich in vitamins A, D, E, and K and also contains 300 types of enzymes to increase gut health.

By Nature

  • Organic
  • Conventional

By Bovine

  • Liquid
  • Powder
  • Capsules
  • Tablets

By Distribution Channel

  • Hypermarkets/Supermarkets
  • Specialty stores
  • Convenience stores
  • Others

By Application

  • Dietary Supplements
  • Functional Food
  • Animal Nutrition
  • Cosmetics
  • Infant Formula
  • Pharmaceuticals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, Australian infant goat milk formula specialist Nuchev launches its first bovine products targeting school-going children and adults.
  • In April 2021, Kilyos Nutrition and Pantheryx are partnering for the research, development, and commercialization of bovine colostrum solutions in Brazil.

Why Purchase the Report?

  • To visualize the global bovine colostrum market segmentation based on nature, form, distribution channel, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of bovine colostrum market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global bovine colostrum market report would provide approximately 70 tables, 67 figures and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Nature
  • 3.2.Snippet by Form
  • 3.3.Snippet by Distribution Channel
  • 3.4.Snippet by Application
  • 3.5.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increase in Health and Wellness Trends
      • 4.1.1.2.Increasing Prevalences of Colostrum Cancers
    • 4.1.2.Restraints
      • 4.1.2.1.Rising Prevalence of Lactose Intolerance
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Nature

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 7.1.2.Market Attractiveness Index, By Nature
  • 7.2.Organic*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Conventional

8.By Form

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2.Market Attractiveness Index, By Form
  • 8.2.Liquid*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Powder
  • 8.4.Capsules
  • 8.5.Tablets

9.By Distribution Channel

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2.Market Attractiveness Index, By Distribution Channel
  • 9.2.Hypermarkets/Supermarkets*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Specialty stores
  • 9.4.Convenience stores
  • 9.5.Others

10.By Application

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2.Market Attractiveness Index, By Application
  • 10.2.Dietary Supplements*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Functional Food
  • 10.4.Animal Nutrition
  • 10.5.Cosmetics
  • 10.6.Infant Formula
  • 10.7.Pharmaceuticals
  • 10.8.Others

11.By Region

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2.Market Attractiveness Index, By Region
  • 11.2.North America
    • 11.2.1.Introduction
    • 11.2.2.Key Region-Specific Dynamics
    • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.6.arket Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1.U.S.
      • 11.2.7.2.Canada
      • 11.2.7.3.Mexico
  • 11.3.Europe
    • 11.3.1.Introduction
    • 11.3.2.Key Region-Specific Dynamics
    • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1.Germany
      • 11.3.7.2.UK
      • 11.3.7.3.France
      • 11.3.7.4.Italy
      • 11.3.7.5.Russia
      • 11.3.7.6.Rest of Europe
  • 11.4.South America
    • 11.4.1.Introduction
    • 11.4.2.Key Region-Specific Dynamics
    • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1.Brazil
      • 11.4.7.2.Argentina
      • 11.4.7.3.Rest of South America
  • 11.5.Asia-Pacific
    • 11.5.1.Introduction
    • 11.5.2.Key Region-Specific Dynamics
    • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1.China
      • 11.5.7.2.India
      • 11.5.7.3.Japan
      • 11.5.7.4.Australia
      • 11.5.7.5.Rest of Asia-Pacific
  • 11.6.Middle East and Africa
    • 11.6.1.Introduction
    • 11.6.2.Key Region-Specific Dynamics
    • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.Colostrum BioTec GmbH*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Key Developments
  • 13.2.Zuche Pharmaceuticals.
  • 13.3.Biodane Pharma A/S
  • 13.4.Agati Healthcare
  • 13.5.Vivesa holding s.r.o.
  • 13.6.Cure Nutraceutical PVT. LTD
  • 13.7.PanTheryx, Inc.
  • 13.8.NOW Health Group, Inc.
  • 13.9.Sterling Technology
  • 13.10.Farbest Brands

LIST NOT EXHAUSTIVE

14.Appendix

  • 14.1.About Us and Services
  • 14.2.Contact Us